Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Random… (NCT07505290) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial for Children With Autism Spectrum Disorder
South Korea60 participantsStarted 2026-02-19
Plain-language summary
This study aims to evaluate the efficacy of the Korean version of the PEERS® for Preschoolers (PEERS®-PS-K), a parent-assisted social skills intervention for preschool-aged children with Autism Spectrum Disorder (ASD). Participants will be randomly assigned to either the intervention group, receiving the PEERS®-PS-K program, or a wait-list control group. The study focuses on improving social skills, such as making friends and interacting with peers, through structured lessons and parent coaching.
Who can participate
Age range4 Years – 6 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Children aged 4 to 6 years (at least 4 years 0 months and less than 7 years diagnosed with Autism Spectrum Disorder (ASD) through standardized diagnostic tools(K-ADOS-2 / K-ADI-R).
* Verbal Intelligence Quotient (VIQ) of 70 or higher on the Korean Wechsler Preschool and Primary Scale of Intelligence (K-WPPSI).
* Native Korean speakers with sufficient verbal fluency to communicate in full sentences appropriate for their age.
* Capable of participating in group activities and language-based interventions as determined through a screening procedure.
* Parents or legal guardians who understand the study's purpose and provide voluntary informed consent for both themselves and their child.
Exclusion Criteria:
* Parents or legal guardians who do not consent to their child's participation in the study.
* Presence of intellectual disability or other comorbid psychiatric conditions that may interfere with study participation.
* Children exhibiting clinically significant challenging behaviors that could disrupt group sessions.
* Other clinically significant neurological, medical, visual, or hearing impairments.
What they're measuring
1
Change from Baseline in SRS-2 Total T-score at 16 weeks
Timeframe: Baseline, Post-intervention (16 weeks), and Follow-up (32 weeks)